Active Ingredients

Advanced Search

Side Effect Reporting

Search Medicine Database

Home Medicines Active Ingredients Companies DHPC Advanced Search Side Effect Reporting

Home
Active Ingredients
quizartinib

quizartinib

Medicine

Status

Monitoring

SPC

PIL

XPIL

Legal Category

Active Ingredient(s)

Company

VANFLYTA 17.7 mg and 26.5 mg film-coated tablets

Updated

Yes

A

Daiichi Sankyo Ireland Ltd

Brought to you by

About

Help
About
Contact Us

Legal

Privacy Statement
Terms & Conditions
Accessibility

Search

Medicines
Active Ingredients
Companies

Award

Designed by eConcept Web Solutions

Direct Healthcare Professional Communications

Documents associated with this medicine were updated in the last 30 days.

Product subject to medical prescription which may not be renewed (A)